Roles of macrolides in treatment of lung injury

  • Arata Azuma
Part of the Progress in Inflammation Research book series (PIR)


Lung Injury Acute Lung Injury Nasal Polyp Antimicrob Agent Macrolide Antibiotic 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M (1998) Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin treatment. Am J Respir Crit Care Med 157: 1829–32PubMedGoogle Scholar
  2. 2.
    Koch CC, Esteban DJ, Chin AC, Olson ME, Read RR, Ceri H, Morck DW, Buret AG (2000) Apoptosis, oxidative metabolism and interleukin-8 production in human neutrophils exposed to azithromycin: effects of Streptococcus pneumoniae. J Antimicrob Chemother 46(1): 19–26CrossRefPubMedGoogle Scholar
  3. 3.
    Chin AC, Lee WD, Murrin KA, Morck DW, Merrill JK, Dick P, Buret AG (2000) Tilmicosin induces apoptosis in bovine peripheral neutrophils in the presence or in the absence of Pasteurella haemolytica and promotes neutrophil phagocytosis by macrophages. Antimicrob Agents Chemother 44(9): 2465–70CrossRefPubMedGoogle Scholar
  4. 4.
    Tamaoki J, Kondo M, Kohri K, Aoshiba K, Tagaya E, Nagai A (1999) Macrolide antibiotics protect against immune complex-induced lung injury in rats: role of nitric oxide from alveolar macrophages. J Immunol 163(5): 2909–15PubMedGoogle Scholar
  5. 5.
    Tamaoki J, Tagaya E, Yamawaki I, Sakai N, Nagai A, Konno K (1995) Effect of erythromycin on endotoxin-induced microvascular leakage in the rat trachea and lungs. Am J Respir Crit Care Med 151(5): 1582–8PubMedGoogle Scholar
  6. 6.
    Sato K, Suga M, Akaike T, Fujii S, Muranaka H, Doi T, Maeda H, Ando M (1998) Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. Am J Respir Crit Care Med 157(3 Pt 1): 853–7PubMedGoogle Scholar
  7. 7.
    Azuma A, Furuta T, Enomoto T, Hashimoto Y, Uematsu K, Nukariya N, Murata A, Kudoh S (1998) Preventive effect of erythromycin on experimental bleomycin-induced acute lung injury in rats. Thorax 53(3): 186–9PubMedGoogle Scholar
  8. 8.
    Li Y, Azuma A, Takahashi S, Usuki J, Matsuda K, Aoyama A, Kudoh S (2002) Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice. Chest 122(6): 2137–45CrossRefPubMedGoogle Scholar
  9. 9.
    Nonaka M, Pawankar R, Tomiyama S, Yagi A (1999) macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 13(4): 267–72PubMedGoogle Scholar
  10. 10.
    Kawashima M, Yatsunami J, Fukuno Y, Nagata M, Tominaga M, Hayashi S (2002) Inhibitory effects of 14-membered ring macrolide antibiotics on bleomycin-induced acute lung injury. Lung 180(2): 73–89PubMedGoogle Scholar
  11. 11.
    Vazifeh D, Preira A, Bryskier A, Labro (1998) Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils. Antimicrob Agents Chemother 42(8): 1944–51PubMedGoogle Scholar
  12. 12.
    Mokgobu I, Theron AJ, Anderson R, Feldman C (1999) The ketolide antimicrobial agent HMR-3004 inhibits neutrophil superoxide production by a membrane-stabilizing mechanism. Int J Immunopharmacol 21(6): 365–77CrossRefPubMedGoogle Scholar
  13. 13.
    Vazifeh D, Bryskier A, Labro MT (2000) Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils. Chemother 44(3): 511–21Google Scholar
  14. 14.
    Duong M, Simard M, Bergeron Y, Bergeron MG (2001) Kinetic study of the inflammatory response in Streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004. Antimicrob Agents Chemother 45(1): 252–62CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2005

Authors and Affiliations

  • Arata Azuma
    • 1
  1. 1.Fourth Department of Internal MedicineNippon Medical SchoolJapan

Personalised recommendations